These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 21913724)

  • 1. Mass spectrometry analysis and quantitation of peptides presented on the MHC II molecules of mouse spleen dendritic cells.
    Bozzacco L; Yu H; Zebroski HA; Dengjel J; Deng H; Mojsov S; Steinman RM
    J Proteome Res; 2011 Nov; 10(11):5016-30. PubMed ID: 21913724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strategy for identifying dendritic cell-processed CD4+ T cell epitopes from the HIV gag p24 protein.
    Bozzacco L; Yu H; Dengjel J; Trumpfheller C; Zebroski HA; Zhang N; Küttner V; Ueberheide BM; Deng H; Chait BT; Steinman RM; Mojsov S; Fenyö D
    PLoS One; 2012; 7(7):e41897. PubMed ID: 22860026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and quantitation of MHC class II-bound peptides from mouse spleen dendritic cells by immunoprecipitation and mass spectrometry analysis.
    Bozzacco L; Yu H
    Methods Mol Biol; 2013; 1061():231-43. PubMed ID: 23963941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinguishing Signal From Noise in Immunopeptidome Studies of Limiting-Abundance Biological Samples: Peptides Presented by I-A
    Nanaware PP; Jurewicz MM; Clement CC; Lu L; Santambrogio L; Stern LJ
    Front Immunol; 2021; 12():658601. PubMed ID: 33995376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Major histocompatibility complex (MHC) class II-peptide complexes arrive at the plasma membrane in cholesterol-rich microclusters.
    Bosch B; Heipertz EL; Drake JR; Roche PA
    J Biol Chem; 2013 May; 288(19):13236-42. PubMed ID: 23532855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T cell reactivity to MHC class II-bound self peptides in systemic lupus erythematosus-prone MRL/lpr mice.
    Suh CH; Freed JH; Cohen PL
    J Immunol; 2003 Feb; 170(4):2229-35. PubMed ID: 12574397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficient presentation of phagocytosed cellular fragments on the major histocompatibility complex class II products of dendritic cells.
    Inaba K; Turley S; Yamaide F; Iyoda T; Mahnke K; Inaba M; Pack M; Subklewe M; Sauter B; Sheff D; Albert M; Bhardwaj N; Mellman I; Steinman RM
    J Exp Med; 1998 Dec; 188(11):2163-73. PubMed ID: 9841929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transport of peptide-MHC class II complexes in developing dendritic cells.
    Turley SJ; Inaba K; Garrett WS; Ebersold M; Unternaehrer J; Steinman RM; Mellman I
    Science; 2000 Apr; 288(5465):522-7. PubMed ID: 10775112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo MHC class II presentation of cytosolic proteins revealed by rapid automated tandem mass spectrometry and functional analyses.
    Dongre AR; Kovats S; deRoos P; McCormack AL; Nakagawa T; Paharkova-Vatchkova V; Eng J; Caldwell H; Yates JR; Rudensky AY
    Eur J Immunol; 2001 May; 31(5):1485-94. PubMed ID: 11465105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antigen presentation capacity and cytokine production by murine splenic dendritic cell subsets upon Salmonella encounter.
    Yrlid U; Wick MJ
    J Immunol; 2002 Jul; 169(1):108-16. PubMed ID: 12077235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The protease inhibitor cystatin C is differentially expressed among dendritic cell populations, but does not control antigen presentation.
    El-Sukkari D; Wilson NS; Hakansson K; Steptoe RJ; Grubb A; Shortman K; Villadangos JA
    J Immunol; 2003 Nov; 171(10):5003-11. PubMed ID: 14607896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonobese diabetic mice display elevated levels of class II-associated invariant chain peptide associated with I-Ag7 on the cell surface.
    Bhatnagar A; Milburn PJ; Lobigs M; Blanden RV; Gautam AM
    J Immunol; 2001 Apr; 166(7):4490-7. PubMed ID: 11254705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The formation of immunogenic major histocompatibility complex class II-peptide ligands in lysosomal compartments of dendritic cells is regulated by inflammatory stimuli.
    Inaba K; Turley S; Iyoda T; Yamaide F; Shimoyama S; Reis e Sousa C; Germain RN; Mellman I; Steinman RM
    J Exp Med; 2000 Mar; 191(6):927-36. PubMed ID: 10727455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-specific CD4+ T cells are activated by "cross-dressed" dendritic cells presenting peptide-MHC class II complexes acquired from cell-based cancer vaccines.
    Dolan BP; Gibbs KD; Ostrand-Rosenberg S
    J Immunol; 2006 Feb; 176(3):1447-55. PubMed ID: 16424172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Presentation of a self-peptide for in vivo tolerance induction of CD4+ T cells is governed by a processing factor that maps to the class II region of the major histocompatibility complex locus.
    Fedoseyeva EV; Tam RC; Orr PL; Garovoy MR; Benichou G
    J Exp Med; 1995 Nov; 182(5):1481-91. PubMed ID: 7595218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of decreasing the affinity of the class II-associated invariant chain peptide on the MHC class II peptide repertoire in the presence or absence of H-2M.
    Honey K; Forbush K; Jensen PE; Rudensky AY
    J Immunol; 2004 Apr; 172(7):4142-50. PubMed ID: 15034026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dendritic cells constitutively present self antigens in their immature state in vivo and regulate antigen presentation by controlling the rates of MHC class II synthesis and endocytosis.
    Wilson NS; El-Sukkari D; Villadangos JA
    Blood; 2004 Mar; 103(6):2187-95. PubMed ID: 14604956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of MHC class I presentation of exogenous antigen by dendritic cells is controlled by CD4+ T cells engaging class II molecules in cholesterol-rich domains.
    Machy P; Serre K; Baillet M; Leserman L
    J Immunol; 2002 Feb; 168(3):1172-80. PubMed ID: 11801652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Masking of a cathepsin G cleavage site in vivo contributes to the proteolytic resistance of major histocompatibility complex class II molecules.
    Burster T; Macmillan H; Hou T; Schilling J; Truong P; Boehm BO; Zou F; Lau K; Strohman M; Schaffert S; Busch R; Mellins ED
    Immunology; 2010 Jul; 130(3):436-46. PubMed ID: 20331476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD9 Regulates Major Histocompatibility Complex Class II Trafficking in Monocyte-Derived Dendritic Cells.
    Rocha-Perugini V; Martínez Del Hoyo G; González-Granado JM; Ramírez-Huesca M; Zorita V; Rubinstein E; Boucheix C; Sánchez-Madrid F
    Mol Cell Biol; 2017 Aug; 37(15):. PubMed ID: 28533221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.